<?xml version="1.0" encoding="UTF-8"?>
<p>The medicinal herbs also showed noteworthy 
 <italic>in vitro</italic> inhibitory activity by inhibiting protease to combat HCV (
 <xref rid="B83" ref-type="bibr">Hussein et al., 2000</xref>). Recent reports on natural products highlighted the flavonoid antiviral activity against HCV in different steps of its life cycle. Ladanein blocked the entry phase and quercetin, luteolin, and apigenin inhibited the replication phase. Honokiol, as a lignan, inhibited either entry or replication phases of HCV (
 <xref rid="B14" ref-type="bibr">Calland et al., 2012</xref>). Silymarin also inhibited HCV in different stages, including fusion, assembly (as naringenin blocked this phase) and transmission (
 <xref rid="B14" ref-type="bibr">Calland et al., 2012</xref>). It also displayed immunomodulatory and anti-inflammatory effects, contributed to its hepatoprotective effects (
 <xref rid="B163" ref-type="bibr">Morishima et al., 2010</xref>). The 
 <italic>Sophora</italic> alkaloids also showed the antiviral potential to inhibit liver fibrosis, reduce the destruction of liver cells, inhibit viral replication, and promote the bile flow (
 <xref rid="B143" ref-type="bibr">Liu et al., 2003</xref>).
</p>
